SGK3 (D42C2) Rabbit mAb 8573S from Cell Signaling Technology

Product Specs
ItemSGK3 (D42C2) Rabbit mAb
CompanyCell Signaling Technology
Price $339.00 Inquire
Catalog Number8573S
ClonalityMonoclonal
NCBI Full Gene Nameserum/glucocorticoid regulated kinase family member 3
ApplicationsWB, IP
ReactivityHu, Ms, Rt, Mk
Research AreaPI3K / Akt Signaling
IsotypeIgG
CloneD42C2
Molecular Weight61
NCBI Gene AliasesCISK, SGK2, SGKL
HostRabbit
TargetSGK3
Quantity100 µl

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney diseaseFrontiers in pharmacologyJanuary 1, 2023Shu H, Wang Y, Zhang H, Dong Q, Sun L, Tu Y, Liao Q, Feng L, Yao L.from AKI to CKD. 2 Materials and methods 2.1 Reagents and antibodies Polyclonal rabbit anti-SGK3 (#8573), anti-Arg1 (#93668), and polyclonal rabbit anti-TOPK (#4942) antibodies were provided by Cell Signaling Technology

(2) The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor CortexJournal of Clinical MedicineJune 15, 2022Maja RogiÄ‡ VidakoviÄ‡, Ivana GunjaÄa, Josipa BukiÄ‡, Vana KoÅ¡ta, JoÅ¡ko Å oda, Ivan KonstantinoviÄ‡, Braco BoÅ¡koviÄ‡, Irena BiliÄ‡, Nikolina ReÅ¾iÄ‡ MuÅ¾iniÄ‡post-DBS compared to pre-DBS, and with stimulatoron compared to stimulator off" Krüger et al. [79],2,8573,F,Adductor,Essential limb tremor with laryngeal dystonia,Bilateral ventrointermediate (VIM) nucleus

(3) Serine/Threonine‐Protein Kinase 3 Facilitates Myocardial Repair After Cardiac Injury Possibly Through the Glycogen Synthase Kinase‐3β/β‐Catenin PathwayJournal of the American Heart AssociationNovember 16, 2021Ya‐Fei Li et al.°C. Specific primary antibody information is as follows: anti‐SGK3 (cell signaling technology [CST]; 8573S), anti‐phospho‐SGK3 (Thr320) (CST; 5642S), anti‐GSK‐3β (CST; 12456T), anti‐phospho‐GSK‐3β (CST; 5558T),

(4) Precision therapeutic targeting of human cancer cell motilityNature communicationsJune 22, 2018Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, et al.substrate (#8738), CDC37 (#3618), HSP90β (#5087), GST (#2622), phsopho-c-RAF (ser338) (#9427), SGK3 (#8573), GAPDH (#2118), anti-mouse IgG-HRP linked secondary (#7076), and anti-rabbit IgG-HRP linked secondary

(5) Identifying pathogenicity of human variants via paralog-based yeast complementationPLOS GeneticsMay 25, 2017Fan Yang, Song Sun, Guihong Tan, Michael Costanzo, David E. Hill, Marc Vidal, Brenda J. Andrews, Charles Boone, Frederick P. RothPrediction,PPH2 Correct?,Provean Score,Provean Prediction,ProveanCorrect?,Within Aligned Region? CASK,8573,T573I,No,0.6,Damaging,No,0.021,Neutral,Yes,-2.35,Neutral,Yes,No CASK,8573,D471N,No,0.4,Neutral,Yes,0.005,Neutral,Yes,-1.48,Neutral,Yes,No CASK,8573,M438L,No,0.4,Neutral,Yes,0,Neutral,Yes,-1.24,Neutral,Yes,Yes CASK,8573,R430C,No,0.4,Neutral,Yes,0.035,Neutral,Yes,-2.51,Damaging,No,Yes CASK,8573,R28L,Yes,0.8,Damaging,Yes,1,Damaging,Yes,-3.59,Damaging,Yes,Yes CYP19A1,1588,M21T,No,0.6,Damaging,No,0.01,Neutral,Yes,-0.65,Neutral,Yes,No CYP19A1,1588,M85R,Yes,0.8,Damaging,Yes,0.128,Neutral,No,-2.77,Damaging,Yes,Yes CYP19A1,1588,W39R,No,0.4,Neutral,Yes,0.343,Neutral,Yes,-5.16,Damaging,No,Yes CYP19A1,1588,M127R,Yes,0.8,Damaging,Yes,1,Damaging,Yes,-4.87,Damaging,Yes,Yes CYP19A1,1588,Y81C,Yes,0.8,Damaging,Yes,1,Damaging,Yes,-6.87,Damaging,Yes,Yes DHDDS,79947,K42E,Yes,0,Neutral,No,0.786,Damaging,Yes,-3.65,Damaging,Yes,Yes EMG1,10436,D86G,Yes,0.6,Damaging,Yes,1,Damaging,Yes,-6.99,Damaging,Yes,Yes IFT122,55764,G51A,No,0.2,Neutral,Yes,0.016,Neutral,Yes,-4.11,Damaging,No,No IFT122,55764,T91I,No,0.2,Neutral,Yes,0.953,Damaging,No,-3.99,Damaging,No,No IFT122,55764,S373F,Yes,0.6,Damaging,Yes,0.951,Damaging,Yes,-5.038,Damaging,Yes,No IFT122,55764,L99W,No,0.4,Neutral,Yes,0.861,Damaging,No,-0.178,Neutral,Yes,No IFT122,55764,R328W,No,0.2,Neutral,Yes,0.994,Damaging,No,-6.168,Damaging,No,No RAB33B,83452,N148K,Yes,0.8,Damaging,Yes,0.005,Neutral,No,0.6,Neutral,No,No RAB33B,83452,K46Q,Yes,0.8,Damaging,Yes,1,Damaging,Yes,-3.55,Damaging,Yes,Yes RAB33B,83452,P142L,No,0.6,Damaging,No,1,Damaging,No,-9.99,Damaging,No,Yes RAB33B,83452,T177M,No,0.6,Damaging,No,1,Damaging,No,-5.21,Damaging,No,Yes VCP,7415,A232G,Yes,0.6,Damaging,Yes,0.005,Neutral,No,-1.87,Neutral,No,No VCP,7415,I151V,Yes,0.4,Neutral,No,0,Neutral,No,-0.51,Neutral,No,Yes VCP,7415,I27V,No,0.2,Neutral,Yes,0,Neutral,Yes,-0.43,Neutral,Yes,Yes VCP,7415,Q19R,No,0.4,Neutral,Yes,0,Neutral,Yes,0.61,Neutral,Yes,Yes VCP,7415,S171N,No,0,Neutral,Yes,0.004,Neutral,Yes,-1.18,Neutral,Yes,No VCP,7415,T436I,No,0.4,Neutral,Yes,0.236,Neutral,Yes,-3.76,Damaging,No,No VCP,7415,I206F,Yes,0.6,Damaging,Yes,0.983,Damaging,Yes,-3.7,Damaging,Yes,Yes VCP,7415,L198W,Yes,0.6,Damaging,Yes,1,Damaging,Yes,-4.71,Damaging,Yes,Yes VCP,7415,R159G,Yes,0.6,Damaging,Yes,1,Damaging,Yes,-6.56,Damaging,Yes,No VCP,7415,R159C,Yes,0.8,Damaging,Yes,1,Damaging,Yes,-6.31,Damaging,Yes,No VCP,7415,R159H,Yes,0.8,Damaging,Yes,0.517,Damaging,Yes,-2.97,Damaging,Yes,No VCP,7415,R191G,Yes,0.6,Damaging,Yes,0.999,Damaging,Yes,-6.49,Damaging,Yes,Yes VCP,7415,P137L,Yes,0.4,Neutral,No,1,Damaging,Yes,-9.31,Damaging,Yes,Yes VCP,7415,R155G,Yes,0.4,Neutral,No,0.998,Damaging,Yes,-5.18,Damaging,Yes,No Deleteriousness

(6) Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein ENeuroscienceFebruary 20, 2017Zhong J, Cheng C, Liu H, Huang Z, Wu Y, Teng Z, He J, Zhang H, Wu J, Cao F, et al.

Be the First to Write a Review!

SGK3 (D42C2) Rabbit mAb

SGK3 (D42C2) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (6)

Reviews

SGK3 (D42C2) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map